Key Insights

Highlights

Success Rate

85% trial completion

Published Results

14 trials with published results (27%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

9.6%

5 terminated out of 52 trials

Success Rate

85.3%

-1.2% vs benchmark

Late-Stage Pipeline

23%

12 trials in Phase 3/4

Results Transparency

48%

14 of 29 completed with results

Key Signals

14 with results85% success

Data Visualizations

Phase Distribution

38Total
Not Applicable (18)
P 1 (3)
P 2 (5)
P 3 (7)
P 4 (5)

Trial Status

Completed29
Unknown11
Terminated5
Recruiting3
Not Yet Recruiting3
Withdrawn1

Trial Success Rate

85.3%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (52)

Showing 20 of 20 trials
NCT05200936Phase 2Completed

Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial

NCT07341204Not ApplicableNot Yet Recruiting

How Virtual Reality Can Help Neurodivergent Children Improve Their Attention

NCT05354232Not ApplicableRecruitingPrimary

Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

NCT06491836Not ApplicableCompletedPrimary

Oligoantigenic Diet and Core Symptomatology of Children With Attention-Deficit /Hyperactivity Disorder (ADHD).

NCT05406414Not ApplicableCompleted

The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems

NCT01841151Not ApplicableCompletedPrimary

Neurofeedback and Working Memory Training for Children and Adolescents With ADHD

NCT05736458Not ApplicableTerminated

Network Control TMS fMRI

NCT06797570Not ApplicableNot Yet RecruitingPrimary

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

NCT06248229Phase 4Recruiting

A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

NCT03605849Phase 3CompletedPrimary

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

NCT06594536Not ApplicableNot Yet RecruitingPrimary

Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity

NCT03949413CompletedPrimary

Correlation Between Balance and Attention in Children With Attention Deficit Hyperactivity Disorder

NCT06194162Not ApplicableRecruiting

Weighted Blankets for Sleep Disturbance Among Children With ADHD

NCT06064942Not ApplicableCompleted

Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder

NCT06030024Not ApplicableCompletedPrimary

Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder

NCT03948607CompletedPrimary

Neural Mechanisms of Attention Lapses in Adult ADHD

NCT05793216Not ApplicableUnknown

VestibulOTherapy: Vestibular Impact on Learning

NCT02848092Not ApplicableCompletedPrimary

Improving ADHD Teen Driving

NCT04729439Phase 1Unknown

Technology-Enhanced Executive Functioning Intervention for ADHD

NCT04548245UnknownPrimary

Markers of Executive Attention Development in Preschoolers

Scroll to load more

Research Network

Activity Timeline